SEC Form 4 · accession 0001610876-26-000002
Adicet Bio, Inc. · ACET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Chodakewitz
Director
Period of report
Jun 21, 2026
Accepted (ET)
Jun 23, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001720580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.10 | Jun 21, 2026 | A | 4,200 | A | — | Jun 20, 2036 | Common Stock | 4,200 | 4,200 | D |
Explanation of responses
- F1These shares shall vest in full on the earlier to occur of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors.